345830 Galectin-3, Human, Recombinant, E. coli

345830
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitéeDisponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service
      Voir les Prix & la Disponibilité

      Aperçu

      Replacement Information

      Prix & Disponibilité

      Référence DisponibilitéConditionnement Qté Prix Quantité
      345830-100UG
      Récupération des données relatives à la disponibilité...
      Disponibilité limitéeDisponibilité limitée
      En stock 
      Interrompu(e)
      Disponible en quantités limitées
      Disponibilité à confirmer
        Pour le restant : Nous vous tiendrons informé
          Pour le restant : Nous vous tiendrons informé
          Nous vous tiendrons informé
          Contacter le Service Clients
          Contact Customer Service

          Ampoule plast. 100 μg
          Prix en cours de récupération
          Le prix n'a pas pu être récupéré
          La quantité minimale doit être un multiple de
          À la validation de la commande Plus d'informations
          Vous avez sauvegardé ()
           
          Demander le prix
          Description
          OverviewRecombinant, human galectin-3 expressed in E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.
          Catalogue Number345830
          Brand Family Calbiochem®
          SynonymsCBP30, CBP35, εBP, L-29, L-34, Mac-2
          References
          ReferencesLegendre, H., et al. 2003. Mod. Pathol. 16, 491.
          Maeda, M., et al. 2003. J. Biol. Chem. 278, 18938.
          Stock, M., et al. 2003. J. Biol. Chem. 278, 17360.
          Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta 1572, 232.
          Iurisci, I., et al. 2000. Clin. Cancer Res. 6, 1389.
          Oda, Y., et al. 1991. Gene 99, 279.
          Product Information
          FormLyophilized
          FormulationLyophilized from diH₂O.
          Quality LevelMQ100
          Applications
          Biological Information
          Purity≥95% by SDS-PAGE
          Physicochemical Information
          ContaminantsEndotoxin: ≤1.0 EU/µg galectin-3
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped with Blue Ice or with Dry Ice
          Toxicity Standard Handling
          Storage -20°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution refrigerate (4°C). Stock solutions containing lactose are stable for up to 6 months at 4°C. Following dialysis and removal of lactose, stock solutions are stable for up to 4 days at 4°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Galectin-3, Human, Recombinant, E. coli FDS

          Titre

          Fiche de données de sécurité des matériaux (FDS) 

          Galectin-3, Human, Recombinant, E. coli Certificats d'analyse

          TitreNuméro de lot
          345830

          Références bibliographiques

          Aperçu de la référence bibliographique
          Legendre, H., et al. 2003. Mod. Pathol. 16, 491.
          Maeda, M., et al. 2003. J. Biol. Chem. 278, 18938.
          Stock, M., et al. 2003. J. Biol. Chem. 278, 17360.
          Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta 1572, 232.
          Iurisci, I., et al. 2000. Clin. Cancer Res. 6, 1389.
          Oda, Y., et al. 1991. Gene 99, 279.
          Fiche technique

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision30-June-2008 RFH
          SynonymsCBP30, CBP35, εBP, L-29, L-34, Mac-2
          DescriptionRecombinant, human galectin-3 expressed in and purified from E. coli. Galectin-3 is a member of the β-galactoside-binding animal lectins. It has been implicated to be involved in various immunological processes, pre-mRNA splicing, cell adhesion, and tumor invasion. Levels of galectin-3 have been reported to be elevated in several metastatic cancers.
          FormLyophilized
          FormulationLyophilized from diH₂O.
          Purity≥95% by SDS-PAGE
          ContaminantsEndotoxin: ≤1.0 EU/µg galectin-3
          SolubilityReconstitute in sterile PBS. For use in carbohydrate binding studies, lactose should be removed by dialysis.
          Storage -20°C
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution refrigerate (4°C). Stock solutions containing lactose are stable for up to 6 months at 4°C. Following dialysis and removal of lactose, stock solutions are stable for up to 4 days at 4°C.
          Toxicity Standard Handling
          ReferencesLegendre, H., et al. 2003. Mod. Pathol. 16, 491.
          Maeda, M., et al. 2003. J. Biol. Chem. 278, 18938.
          Stock, M., et al. 2003. J. Biol. Chem. 278, 17360.
          Hirabayashi, J., et al. 2002. Biochim. Biophys. Acta 1572, 232.
          Iurisci, I., et al. 2000. Clin. Cancer Res. 6, 1389.
          Oda, Y., et al. 1991. Gene 99, 279.